News & Articles

Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein

Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment

The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy

The integrated platform from industry leaders will remove complexities in the patient journey to benefit all clinical trial stakeholders

Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized

The drug candidate was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated

Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg

This cutting-edge technology has the potential to vastly improve care, offering accessible and affordable brain imaging that can take place at the patient’s bedside

OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients

The acquisition supports Algorics' commitment to expanding its team of experienced analytical professionals and sustaining its commercial growth

The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

New smartphone-sized test device uses innovative ‘lab on chip’ technology for rapid, accurate results

Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally

Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted

Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more